Merck Life Science Commits €13 Million to Bengaluru Plant Expansion
Merck Life Science is expanding its manufacturing facility in Bengaluru, Karnataka, with an investment of €13 million, as reported on 24 September 2026 by BioPharma APAC. The project adds significant capacity to one of Germany's largest science and technology companies in its Indian manufacturing network.
Projects India already tracks a separate Merck Life Science project — a repackaging and distribution centre at Patalganga, Raigarh (MAH), Maharashtra, valued at Rs 126 crore — indicating an active multi-site investment programme by the company in India.
| Detail | Information |
|---|---|
| Promoter | Merck Life Science |
| Project Type | Manufacturing Expansion |
| Location | Bengaluru, Karnataka |
| Investment Value | €13 million |
| Also Tracked (same promoter) | Repackaging & Distribution Centre, Patalganga, Maharashtra — Rs 126 crore |
Karnataka in the Broader Pharma Investment Landscape
Karnataka accounts for 214 of the drugs and pharmaceuticals projects tracked by Projects India nationally, placing it fourth among all states in this sub-sector. Gujarat leads with 606 tracked projects, followed by Telangana with 244 and Andhra Pradesh with 231. Maharashtra accounts for a further 166 projects, with Himachal Pradesh at 59.
The Bengaluru expansion by Merck Life Science reinforces Karnataka's position as a significant destination for pharmaceutical capital investment, particularly for multinational and large-scale operators seeking proximity to research talent and established supply chains in the state.
Pipeline Activity Across Drugs and Pharmaceuticals
Projects India currently tracks 1,791 live projects in the drugs and pharmaceuticals sub-sector under Industrial Projects, with 21 projects added to the database in the last 90 days. The pipeline spans a wide range of investment sizes and project types, from bulk drug manufacturing to active pharmaceutical ingredient (API) plants and formulations units.
Recent projects entering the tracked pipeline include:
- API Bulk Drug & Intermediates Mfg Unit at Sangareddy, Telangana — Rs 195 crore (Chromo Laboratories India Private Limited) — Under Approvals
- Bulk Drugs & Drug Intermediates Mfg Unit at Orvakal Node, Kurnool, Andhra Pradesh — Rs 1,225 crore (Virupaksha Organics Limited) — Planning
- Pharmaceutical Project at Verna, South Goa — Rs 42 crore (Centaur Pharmaceuticals Private Limited) — Construction Started
- Active Pharmaceutical Ingredients Project at Chennai, Tamil Nadu — Rs 20 crore (Juvenus Drugs) — Under Approvals
- Pharmaceutical Products & Intermediates Mfg at Navi Mumbai, Maharashtra — Rs 4.49 crore (Srikem Laboratories Private Limited) — Construction Started
Stage Breakdown: Where Projects Stand Nationally
Of the 1,791 tracked projects in drugs and pharmaceuticals, the largest share — 637 — are currently Under Approvals, representing a substantial forward pipeline of work that has not yet reached the construction stage. A further 361 projects are at Construction Started, meaning active on-site activity is under way at those locations. The breakdown by stage is as follows:
- Under Approvals: 637
- Construction Started: 361
- Completed: 323
- Approvals Received: 137
- Hold: 137
- Planning: 98
The high volume of projects in the Under Approvals and Approvals Received stages — nearly 774 projects in aggregate — suggests a strong near-term construction pipeline for the sector, with significant potential for equipment procurement, civil contracting and engineering services activity in the months ahead.
What this means for suppliers and contractors
The Merck Life Science expansion in Bengaluru signals continued multinational commitment to pharmaceutical manufacturing capacity in Karnataka, a state that already hosts 214 tracked projects. For suppliers of laboratory equipment, cleanroom systems, process utilities, and pharmaceutical-grade construction materials, Karnataka's established base and the Bengaluru site's global operator profile make it a market worth monitoring closely.
More broadly, the national pipeline tracked by Projects India — with 637 projects Under Approvals and 361 at Construction Started — indicates substantial near-term demand for civil contractors, process equipment vendors, validation service providers and specialist subcontractors across Gujarat, Telangana, Andhra Pradesh, Karnataka and Maharashtra. Suppliers seeking early-stage project intelligence across all tracked projects can filter by state, stage and sub-sector to identify the most relevant opportunities before procurement processes open.
Frequently asked questions
How much is Merck Life Science investing in Bengaluru?
Merck Life Science is investing €13 million in expanding its manufacturing facility in Bengaluru, Karnataka, as reported by BioPharma APAC on 24 September 2026. No further breakdown of the investment scope was available from the source headline.
Does Merck Life Science have other projects in India?
Projects India tracks a separate Merck Life Science project — a repackaging and distribution centre at Patalganga, Raigarh (MAH), Maharashtra, valued at Rs 126 crore — in addition to the newly reported Bengaluru manufacturing expansion.
How many pharma manufacturing projects are active in Karnataka?
Projects India tracks 214 drugs and pharmaceuticals projects in Karnataka, placing the state fourth nationally behind Gujarat (606), Telangana (244) and Andhra Pradesh (231).
How many drugs and pharmaceuticals projects are currently tracked in India?
Projects India tracks 1,791 live projects in the drugs and pharmaceuticals sub-sector across India, with 21 projects added in the last 90 days. Of these, 637 are Under Approvals and 361 are at the Construction Started stage.
